摘要
Objective： To investigate the antinociceptive effects of Riluzole administered intraperitoneally in three hyperalgesia model of mice. Methods： Antinociceptive tests in C57BL mice were investigated with formalin test,acetic acid induced writhing test and tail-immersion test. The effects of intraperitoneally Riluzole 2 mg/kg ,4 mg/kg and 8 mg/kg on the pain threshold were observed. Result： We found that i.p. treatment with Riluzole （4 mg/kg and 8 mg/kg） blocked the second phase flinching behavior compared with vehicle （P 〈 0.05）, but not during the first phase in the formalin test. In addition to the formalin test, Riluzole at different dose （from 2 to 8 mg/kg） attenuated acetic acid induced writhing response when compared to vehicle group （P 〈 0.05）. In the tail-immersion test, Riluzole at the highest dose （8 mg/kg） caused significant increase in tail flick response latency as compared to vehicle animals or compared with Baseline （P 〈 0.05）. Conclusion： Our results suggest that glutamate release inhibitor Riluzole can attenuate nociceptive behavior and has differrent antinociceptive characteristic according to the various pain models.
Objective： To investigate the antinociceptive effects of Riluzole administered intraperitoneally in three hyperalgesia model of mice. Methods： Antinociceptive tests in C57BL mice were investigated with formalin test,acetic acid induced writhing test and tail-immersion test. The effects of intraperitoneally Riluzole 2 mg/kg ,4 mg/kg and 8 mg/kg on the pain threshold were observed. Result： We found that i.p. treatment with Riluzole （4 mg/kg and 8 mg/kg） blocked the second phase flinching behavior compared with vehicle （P 〈 0.05）, but not during the first phase in the formalin test. In addition to the formalin test, Riluzole at different dose （from 2 to 8 mg/kg） attenuated acetic acid induced writhing response when compared to vehicle group （P 〈 0.05）. In the tail-immersion test, Riluzole at the highest dose （8 mg/kg） caused significant increase in tail flick response latency as compared to vehicle animals or compared with Baseline （P 〈 0.05）. Conclusion： Our results suggest that glutamate release inhibitor Riluzole can attenuate nociceptive behavior and has differrent antinociceptive characteristic according to the various pain models.
基金
Key Laboratory Foundation of Jiangsu Province Department of Health(WK200501)
